Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model

References

• Salehi M, Wenick AS, Law HA, Evans JR, Gehlbach P. Interventions for central serous chorioretinopathy: a network meta-analysis. Cochrane Database Syst Rev. 2015;12. doi:10.1002/14651858.CD011841.pub2
   Google Scholar
• Gass DM. Atlas of Macular Diseases. St Louis: CV Mosby Co; 1987.
   Google Scholar
• Wong KH, Lau KP, Chhablani J, Tao Y, Li Q, Wong IY. Central serous chorioretinopathy: what we have learnt so far. Acta Ophthalmol. 2016;94(4):321–325. doi:10.1111/aos.12779
   PubMed Web of Science ®Google Scholar
• Zhao M, Célérier I, Bousquet E, et al. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest. 2012;122(7):2672–2679. doi:10.1172/JCI61427
   PubMed Web of Science ®Google Scholar
• Savaskan E, Löffler KU, Meier F, Müller-Spahn F, Flammer J, Meyer P. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Res. 2004;36(6):312–320. doi:10.1159/000081633
   PubMed Web of Science ®Google Scholar
• Nakashima H, Suzuki H, Ohtsu H, et al. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol. 2005. doi:10.2174/157016106775203126
   Google Scholar
• Fusi-Rubiano W, Saedon H, Patel V, Yang YC. Oral medications for central serous chorioretinopathy: a literature review. Eye. 2020;34(5):809–824. doi:10.1038/s41433-019-0568-y
   PubMed Web of Science ®Google Scholar
• Özdemir S, Çelik B, Sümer E, Acar ET, Üner M. Eplerenone nanoemulsions for treatment of hypertension. Part II: physical stability assessment and in vivo study. J Drug Deliv Sci Technol. 2018;45:287–295. doi:10.1016/j.jddst.2018.03.014
   Google Scholar
• Zhao M, Valamanesh F, Celerier I, et al. The neuroretina is a novel mineralocorticoid target: aldosterone up‐regulates ion and water channels in Müller glial cells. FASEB J. 2010;24(9):3405–3415. doi:10.1096/fj.09-154344
   PubMed Web of Science ®Google Scholar
• Yang D, Eliott D. Systemic mineralocorticoid antagonists in the treatment of central serous chorioretinopathy. Semin Ophthalmol. 2017;32(1):36–42. doi:10.1080/08820538.2016.1228418
   PubMed Web of Science ®Google Scholar
• Campos Polo R, Rubio Sánchez C, García Guisado DM, Díaz Luque MJ. Eplerenone, a new treatment for an old problem: retinitis pigmentosa with recalcitrant macular edema. Arch La Soc Española Oftalmol (English Ed. 2018;93(1):38–41. doi:10.1016/j.oftale.2017.05.012
   PubMedGoogle Scholar
• Chatziralli I, Vlachodimitropoulou A, Daoula C, et al. Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature. Int J Retin Vitr. 2018;4(1):1–5. doi:10.1186/s40942-018-0137-8
   PubMedGoogle Scholar
• Bin-Jumah M, Gilani SJ, Jahangir MA, et al. Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity. Int J Nanomedicine. 2020;15:7861–7875. doi:10.2147/IJN.S269004
   PubMed Web of Science ®Google Scholar
• Tian B, Luo Q, Song S, et al. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery. J Pharm Sci. 2012;101(3):1040–1049. doi:10.1002/jps.22813
   PubMedGoogle Scholar
• Afzal M, Zafar A, Imam SS. Stimulus responsive ocular gentamycin-ferrying chitosan nanoparticles hydrogel: formulation optimization, ocular safety and antibacterial assessment. Int J Nanomed. 2020;15:4717–4737. doi:10.2147/IJN.S254763
   PubMedGoogle Scholar
• Iqbal MA, Md S, Sahni JK, Baboota S, Dang S, Ali J. Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target. 2012;20(10):813–830. doi:10.3109/1061186X.2012.716845
   PubMed Web of Science ®Google Scholar
• Liu R, Wang S, Sun L, et al. A novel cationic nanostructured lipid carrier for improvement of ocular bioavailability: design, optimization, in vitro and in vivo evaluation. J Drug Deliv Sci Technol. 2016;33:28–36. doi:10.1016/j.jddst.2016.03.009
   Google Scholar
• Li X, Nie S-F, Kong J, Li N, Ju C-Y, Pan W-S. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm. 2008;363(1–2):177–182. doi:10.1016/j.ijpharm.2008.07.017
   PubMedGoogle Scholar
• Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gurny R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm. 1999;180(2):185–193. doi:10.1016/S0378-5173(99)00003-4
   PubMed Web of Science ®Google Scholar
• Chowdary KPR, Rao YS. Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull. 2004;27(11):1717–1724. doi:10.1248/bpb.27.1717
   PubMed Web of Science ®Google Scholar
• Qi H, Chen W, Huang C, et al. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm. 2007;337(1–2):178–187. doi:10.1016/j.ijpharm.2006.12.038
   PubMed Web of Science ®Google Scholar
• Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57(11):1556–1568. doi:10.1016/j.addr.2005.07.001
   PubMed Web of Science ®Google Scholar
• Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res. 2000;19(3):323–344. doi:10.1016/S1350-9462(99)00016-6
   PubMed Web of Science ®Google Scholar
• Clark SJ, Keenan TDL, Fielder HL, et al. Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera. Investig Ophthalmol Vis Sci. 2011;52(9):6511. doi:10.1167/iovs.11-7909
   PubMed Web of Science ®Google Scholar
• Xu X, Jha AK, Harrington DA, Farach-Carson MC, Jia X. Hyaluronic acid-based hydrogels: from a natural polysaccharide to complex networks. Soft Matter. 2012;8(12):3280. doi:10.1039/c2sm06463d
   PubMed Web of Science ®Google Scholar
• Kashikar VS. Ophthalmic mucoadhesive polymers-A literature review. Int J Pharm Sci Rev Res. 2011;7:68–73.
   Google Scholar
• Boddeda B, Ratna JV, Battu H. A review on mucoadhesive polymers in ophthalmics. Int J Pharm Sci Rev Res. 2014;24:237–45.
   Google Scholar
• Luo Q, Zhao J, Zhang X, Pan W. Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm. 2011;403(1–2):185–191. doi:10.1016/j.ijpharm.2010.10.013
   PubMed Web of Science ®Google Scholar
• El‐Samaligy MS, Rohdewald P. Reconstituted collagen nanoparticles, a novel drug carrier delivery system. J Pharm Pharmacol. 1983;35(8):537–539. doi:10.1111/j.2042-7158.1983.tb04831.x
   PubMedGoogle Scholar
• Kuwano M, Horibe Y, Kawashima Y. Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery. J Ocul Pharmacol Ther. 1997;13(1):31–40. doi:10.1089/jop.1997.13.31
   PubMedGoogle Scholar
• Geggel HS, Friend J, Thoft RA. Collagen gel for ocular surface. Investig Ophthalmol Vis Sci. 1985;26(6):901–5.
   PubMedGoogle Scholar
• Abd-elhakeem E, El-nabarawi M, Shamma R. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: in- vitro optimization and ex-vivo assessment. Drug Deliv. 2021;28(1):642–654. doi:10.1080/10717544.2021.1902023
   PubMed Web of Science ®Google Scholar
• Shamma RN, Aburahma MH, Aburahma MH. Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia. Int J Nanomedicine. 2014;9:5449–5460. doi:10.2147/IJN.S73010
   PubMed Web of Science ®Google Scholar
• Tung IC. Rheological behavior of poloxamer 407 aqueous solutions during sol-gel and dehydration processes. Int J Pharm. 1994;107(2):85–90. doi:10.1016/0378-5173(94)90445-6
   Google Scholar
• Marques MRC, Loebenberg R, Almukainzi M. Simulated biological fluids with possible application in dissolution testing. Dissolution Technol. 2011;18(3):15–28. doi:10.14227/DT180311P15
   Web of Science ®Google Scholar
• Emad Eldeeb A, Salah S, Ghorab M. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv. 2019;26(1):509–521. doi:10.1080/10717544.2019.1609622
   PubMed Web of Science ®Google Scholar
• Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Drug Deliv. 2018;25(1):1340–1349. doi:10.1080/10717544.2018.1477861
   PubMed Web of Science ®Google Scholar
• Younes NF, Abdel-Halim SA, Elassasy AI. Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm. 2018;553(1–2):386–397. doi:10.1016/j.ijpharm.2018.10.057
   PubMed Web of Science ®Google Scholar
• Elkasabgy NA. Ocular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailability. Int J Pharm. 2014;460(1–2):33–44. doi:10.1016/j.ijpharm.2013.10.044
   PubMedGoogle Scholar
• Luepke NP, Kemper FH. The HET-CAM test: an alternative to the draize eye test. Food Chem Toxicol. 1986;24(6–7):495–496. doi:10.1016/0278-6915(86)90099-2
   Web of Science ®Google Scholar
• Alany RG, Rades T, Nicoll J, Tucker IG, Davies NM. W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention. J Control Release. 2006;111(1–2):145–152. doi:10.1016/j.jconrel.2005.11.020
   PubMed Web of Science ®Google Scholar
• Badawi AA, El-laithy HM, Qidra RK, Mofty H, El M. Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res. 2008;31(8):1040–1049. doi:10.1007/s12272-001-1266-6
   PubMed Web of Science ®Google Scholar
• Draize JH. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377–90.
   Web of Science ®Google Scholar
• Wilhelmus KR. The draize eye test. Surv Ophthalmol. 2001;45(6):493–515. doi:10.1016/S0039-6257(01)00211-9
   PubMed Web of Science ®Google Scholar
• Liu Z, Nie S, Guo H, Pan W, Li J. Effects of transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. J Pharm Pharmacol. 2006. doi:10.1211/jpp.58.1.0006
   Google Scholar
• Yousry C, Zikry PM, Salem HM, Basalious EB, El-Gazayerly ON. Integrated nanovesicular/self-nanoemulsifying system (INV/SNES) for enhanced dual ocular drug delivery: statistical optimization, in vitro and in vivo evaluation. Drug Deliv Transl Res. 2020;10(3):801–814. doi:10.1007/s13346-020-00716-5
   PubMedGoogle Scholar
• Warren B. Theory and practice of histological techniques. Pathology. 1996;28(4):381. doi:10.1016/s0031-3025(16)35146-7
   Google Scholar
• Sayed S, Abdel-Moteleb M, Amin MM, Khowessah OM. Cubogel as potential platform for glaucoma management. Drug Deliv. 2021;28(1):293–305. doi:10.1080/10717544.2021.1872740
   PubMed Web of Science ®Google Scholar
• Pai RV, Vavia PR. Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: effect on ocular disposition. Int J Pharm. 2020;577:119095. doi:10.1016/j.ijpharm.2020.119095
   PubMedGoogle Scholar
• Abdelbary AA, Abd-Elsalam WH, Al-mahallawi AM. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment. Int J Pharm. 2016;513(1–2):688–696. doi:10.1016/j.ijpharm.2016.10.006
   PubMed Web of Science ®Google Scholar
• Sayed S, Elsayed I, Ismail MM. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug. Int J Pharm. 2018;549(1–2):249–260. doi:10.1016/j.ijpharm.2018.08.001
   PubMedGoogle Scholar
• Elsayed I, Sayed S. Tailored nanostructured platforms for boosting transcorneal permeation: box–Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization. Int J Nanomedicine. 2017;12:7947–7962. doi:10.2147/IJN.S150366
   PubMed Web of Science ®Google Scholar
• Tian BC, Zhang WJ, Xu HM, et al. Further investigation of nanostructured lipid carriers as an ocular delivery system: in vivo transcorneal mechanism and in vitro release study. Colloids Surf B. 2013;102:251–256. doi:10.1016/j.colsurfb.2012.08.021
   PubMed Web of Science ®Google Scholar
• Zhang W, Li X, Ye T, et al. Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions. Int J Nanomedicine. 2014;9:4305–4315. doi:10.2147/IJN.S63414
   PubMed Web of Science ®Google Scholar
• Gasco MR, Saettone MF, Zara GP. Pharmaceutical compositions suitable for the treatment of ophthalmic diseases. 2006.
   Google Scholar
• Sánchez-López E, Espina M, Doktorovova S, Souto EB, García ML. Lipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye – part II - Ocular drug-loaded lipid nanoparticles. Eur J Pharm Biopharm. 2017. doi:10.1016/j.ejpb.2016.10.013
   Google Scholar
• Leonardi A, Bucolo C, Romano GL, et al. Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. Int J Pharm. 2014;470(1–2):133–140. doi:10.1016/j.ijpharm.2014.04.061
   PubMedGoogle Scholar
• Yousry C, Elkheshen SA, El-laithy HM, Essam T, Fahmy RH. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery. Eur J Pharm Sci. 2017;100:142–154. doi:10.1016/j.ejps.2017.01.013
   PubMed Web of Science ®Google Scholar
• Janoria KG, Gunda S, Boddu SHS, Mitra AK. Novel approaches to retinal drug delivery. Expert Opin Drug Deliv. 2007;4(4):371–388. doi:10.1517/17425247.4.4.371
   PubMed Web of Science ®Google Scholar
• Kamal HI, El-leithy IS, Makky AA. Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy. Molecular Pharmaceutics. 2010;(1):337–342.
   PubMedGoogle Scholar
• Barbault-Foucher S, Gref R, Russo P, Guechot J, Bochot A. Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery. J Control Release. 2002;83(3):365–375. doi:10.1016/S0168-3659(02)00207-9
   PubMedGoogle Scholar
• Kalam MA. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Int J Biol Macromol. 2016. doi:10.1016/j.ijbiomac.2016.04.070
   Google Scholar
• Zewail M, Nafee N, Helmy MW, Boraie N. Coated nanostructured lipid carriers targeting the joints – an effective and safe approach for the oral management of rheumatoid arthritis. Int J Pharm. 2019;567:118447. doi:10.1016/j.ijpharm.2019.118447
   PubMed Web of Science ®Google Scholar
• Fahmy AM, Hassan M, El-Setouhy DA, Tayel SA, Al-Mahallawi AM. Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design: in vitro characterization and in vivo evaluation. Drug Deliv. 2021;28(1):77–86. doi:10.1080/10717544.2020.1858997
   PubMed Web of Science ®Google Scholar
• Neslihan U, Gökçe EH, Bozbiyik DI, Eǧrilmez S, Özer Ö, Ertan G. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Eur J Pharm Sci. 2014;63:204–215. doi:10.1016/j.ejps.2014.07.013
   PubMedGoogle Scholar
• Jain A, Mishra SK, Vuddanda PR, Singh SK, Singh R, Singh S. Targeting of diacerein loaded lipid nanoparticles to intra-articular cartilage using chondroitin sulfate as homing carrier for treatment of osteoarthritis in rats. Nanomed Nanotechnol Biol Med. 2014;10(5):e1031–e1040. doi:10.1016/j.nano.2014.01.008
   PubMed Web of Science ®Google Scholar
• Pal SL. Nanoparticle: an overview of preparation and characterization. J Appl Pharm Sci. 2011;1(6):228–34.
   Google Scholar
• Grant J, Allen C. Chitosan as a Biomaterial for Preparation of Depot-Based Delivery Systems. ACS Symposium Series. 2006.
   Google Scholar
• Balguri SP, Adelli GR, Janga KY, Bhagav P, Majumdar S. Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: effect of molecular weight and density of poly (ethylene) glycol. Int J Pharm. 2017;529(1–2):32–43. doi:10.1016/j.ijpharm.2017.06.042
   PubMedGoogle Scholar
• Jain B, Singh B, Katare OP, Vyas SP. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units. J Liposome Res. 2010;20(2):105–114. doi:10.3109/08982100903161449
   PubMed Web of Science ®Google Scholar
• Li J, Liu D, Tan G, Zhao Z, Yang X, Pan W. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin. Carbohydr Polym. 2016;146:435–444. doi:10.1016/j.carbpol.2016.03.079
   PubMed Web of Science ®Google Scholar
• Ogston AG, Stanier JE. The dimensions of the particle of hyaluronic acid complex in synovial fluid. Biochem J. 1951;49(5):585–590. doi:10.1042/bj0490585
   PubMedGoogle Scholar
• Daar E, King L, Nisbet A, Thorpe RB, Bradley DA. Viscosity changes in hyaluronic acid: irradiation and rheological studies. Appl Radiat Isot. 2010;68(4–5):746–750. doi:10.1016/j.apradiso.2009.10.022
   PubMedGoogle Scholar
• Snetkov P, Zakharova K, Morozkina S, Olekhnovich R, Uspenskaya M. Hyaluronic acid: the influence of molecular weight and degradable properties of biopolymer. Polymers (Basel). 2020;12(8):1800. doi:10.3390/polym12081800
   PubMed Web of Science ®Google Scholar
• Lee CH, Singla A, Lee Y. Biomedical applications of collagen. Int J Pharm. 2001;221(1–2):1–22. doi:10.1016/S0378-5173(01)00691-3
   PubMed Web of Science ®Google Scholar
• Graça A, Gonçalves LM, Raposo S, Ribeiro HM, Marto J. Useful in vitro techniques to evaluate the mucoadhesive properties of hyaluronic acid-based ocular delivery systems. Pharmaceutics. 2018;10(3):110. doi:10.3390/pharmaceutics10030110
   PubMed Web of Science ®Google Scholar
• Al-Mahallawi AM, Khowessah OM, Shoukri RA. Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm. 2014;472(1–2):304–314. doi:10.1016/j.ijpharm.2014.06.041
   PubMed Web of Science ®Google Scholar
• Pradhan M, Singh D, Murthy SN, Singh MR. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis. Steroids. 2015;101:56–63. doi:10.1016/j.steroids.2015.05.012
   PubMed Web of Science ®Google Scholar
• Youssef NAHA, Kassem AA, Farid RM, Ismail FA, EL-Massik MAE, Boraie NA. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: preparation, characterization and in vivo evaluation. Int J Pharm. 2018;548(1):609–624. doi:10.1016/j.ijpharm.2018.07.014
   PubMedGoogle Scholar
• Gao X, Zhang J, Xu Q, Huang Z, Wang Y, Shen Q. Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery. Drug Dev Ind Pharm. 2017;43(4):661–667. doi:10.1080/03639045.2016.1275671
   PubMed Web of Science ®Google Scholar
• Bhatta RS, Chandasana H, Chhonker YS, et al. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies. Int J Pharm. 2012;432(1–2):105–112. doi:10.1016/j.ijpharm.2012.04.060
   PubMedGoogle Scholar
• Leung SH, Robinson JR. The contribution of anionic polymer structural features to mucoadhesion. J Control Release. 1987;5(3):223–31. doi:10.1016/0168-3659(88)90021-1
   Google Scholar
• Zeng W, Li Q, Wan T, et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids Surf B. 2016. doi:10.1016/j.colsurfb.2016.01.014
   Google Scholar
• Fathalla ZMA, Khaled KA, Hussein AK, Alany RG, Vangala A. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles. Drug Dev Ind Pharm. 2016;42(4):514–524. doi:10.3109/03639045.2015.1081236
   PubMed Web of Science ®Google Scholar
• Menchicchi B, Fuenzalida JP, Bobbili KB, Hensel A, Swamy MJ, Goycoolea FM. Structure of Chitosan determines its interactions with mucin. Biomacromolecules. 2014;15(10):3550–3558. doi:10.1021/bm5007954
   PubMed Web of Science ®Google Scholar
• Yousry C, Zikry PM, Basalious EB, El-Gazayerly ON. Self-nanoemulsifying system optimization for higher terconazole solubilization and non-irritant ocular administration. Adv Pharm Bull. 2020;10(3):389–398. doi:10.34172/apb.2020.047
   PubMed Web of Science ®Google Scholar
• Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm. 2013;39(11):1599–1617. doi:10.3109/03639045.2012.736515
   PubMed Web of Science ®Google Scholar
• Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech. 2009;10(3). doi:10.1208/s12249-009-9268-4
   Google Scholar
• Eldeeb AE, Salah S, Ghorab M. Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Deliv Sci Technol. 2019;52:236–247. doi:10.1016/j.jddst.2019.04.036
   Web of Science ®Google Scholar
• Moosa RM, Choonara YE, Du Toit LC, et al. In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model. Int J Pharm. 2014;466(1–2):296–306. doi:10.1016/j.ijpharm.2014.02.032
   PubMedGoogle Scholar
• Roggeband R, York M, Pericoi M, Braun W. Eye irritation responses in rabbit and man after single applications of equal volumes of undiluted model liquid detergent products. Food Chem Toxicol. 2000;38(8):727–734. doi:10.1016/S0278-6915(00)00057-0
   PubMed Web of Science ®Google Scholar
• Tian BC., Zhang WJ., Xu HM., et al. Further investigation of nanostructured lipid carriers as an ocular delivery system: In vivo transcorneal mechanism and in vitro release study. Colloids Surfaces B Biointerfaces. 2013 doi:10.1016/j.colsurfb.2012.08.021.
   Google Scholar
• Sayed S, Abdelmoteleb M, Amin MM, Khowessah OM. Effect of formulation variables and gamma sterilization on transcorneal permeation and stability of proniosomal gels as ocular platforms for antiglaucomal drug. AAPS PharmSciTech. 2020;21(3). doi:10.1208/s12249-020-1626-2
   Google Scholar
• Pai RV, Monpara JD, Vavia PR. Exploring molecular dynamics simulation to predict binding with ocular mucin: an in silico approach for screening mucoadhesive materials for ocular retentive delivery systems. J Control Release. 2019;309:190–202. doi:10.1016/j.jconrel.2019.07.037
   PubMedGoogle Scholar
• Bansil R, Turner BS. Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci. 2006;11(2–3):164–170. doi:10.1016/j.cocis.2005.11.001
   Web of Science ®Google Scholar
• Grießinger J, Dünnhaupt S, Cattoz B, et al. Methods to determine the interactions of micro- and nanoparticles with mucus. Eur J Pharm Biopharm. 2015;96:464–476. doi:10.1016/j.ejpb.2015.01.005
   PubMed Web of Science ®Google Scholar